Extended Follow up and Immune Alterations in Patients with Classic Hodgkin Lymphoma (cHL) Treated with Frontline Single Agent Pembrolizumab Followed By AVD Chemotherapy

被引：0
|
作者：
Allen, Pamela B. [1 ]
Bazzi, Latifa [2 ]
Zhang, Bin [3 ]
Chen, Qing [4 ]
Slonim, Liron Barnea [4 ]
Savas, Hatice [5 ]
Advani, Ranjana H. [6 ]
Evens, Andrew M. [7 ]
Pro, Barbara [8 ]
Karmali, Reem [9 ]
Mou, Eric [10 ]
Eisner, Robert [11 ]
Bayer, Robert [11 ]
Gordon, Leo I. [12 ]
Winter, Jane N. [13 ]
机构：
[1] Emory Univ, Dept Hematol, Sch Med, Decatur, GA USA
[2] Northwestern, Biostatist, Chicago, IL USA
[3] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Hematol & Oncol, Chicago, IL USA
[4] Northwestern Hosp, Pathol, Chicago, IL USA
[5] Northwestern, Radiol, Chicago, IL USA
[6] Stanford Univ, Dept Med, Div Oncol & Hematol, Stanford, CA USA
[7] Rutgers Canc Inst, New Brunswick, NJ USA
[8] Columbia Univ, Lymphoma Program, Div Hematol & Oncol, New York, NY USA
[9] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA
[10] Univ Iowa, Div Hematol Oncol & Blood & Marrow Transplantat, Iowa City, IA USA
[11] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
[12] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL USA
[13] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-208680
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1664 / 1665
页数：2
相关论文
共 27 条
  • [11] Nivolumab for Relapsed or Refractory Classical Hodgkin Lymphoma (cHL) after Autologous Hematopoietic Cell Transplantation (auto-HCT): Extended Follow-up of the Phase 2 Single-Arm CheckMate 205 Study
    Armand, Philippe
    Engert, Andreas
    Younes, Anas
    Lee, Hun Ju
    Santoro, Armando
    Zinzani, Pier Luigi
    Timmerman, John M.
    Collins, Graham P.
    Ramchandren, Radhakrishnan
    Cohen, Jonathon B.
    De Boer, Jan Paul
    Savage, Kerry J.
    Kuruvilla, John
    Trneny, Marek
    Shipp, Margaret A.
    Sacchi, Mariana
    Ansell, Anne Sumbuland Stephen M.
    Ansell, Stephen M.
    BLOOD, 2018, 132
  • [12] Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial
    Armand, Philippe
    Engert, Andreas
    Younes, Anas
    Fanale, Michelle
    Santoro, Armando
    Zinzani, Pier Luigi
    Timmerman, John M.
    Collins, Graham P.
    Ramchandren, Radhakrishnan
    Cohen, Jonathon B.
    De Boer, Jan Paul
    Kuruvilla, John
    Savage, Kerry J.
    Trneny, Marek
    Shipp, Margaret A.
    Kato, Kazunobu
    Sumbul, Anne
    Farsaci, Benedetto
    Ansell, Stephen M.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (14) : 1428 - +
  • [13] Long-term follow-up in patients with advanced Hodgkin's disease treated by high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation
    Bragotti, LZ
    Colombo, AA
    Bernasconi, P
    Caldera, D
    Brusamolino, E
    Baratè, C
    Bonfichi, M
    Maffioli, M
    Zaniboni, AA
    Algarotti, A
    Troletti, D
    Lazzarino, M
    Alessandrino, E
    BONE MARROW TRANSPLANTATION, 2006, 37 : S241 - S241
  • [14] Long-term follow-up in aggressive non-Hodgkin's lymphoma (NHL) patients treated with rHuG-CSF(lenograstim) combined biweekly CHOP chemotherapy.
    Dan, K
    Ogura, M
    Oyama, A
    Asano, S
    BLOOD, 2001, 98 (11) : 344A - 344A
  • [15] A Phase II Study(A)over-cap of Sequential Pembrolizumab (PEM)(A)over-cap Followed(A)over-cap By AVD for Frontline Treatment(A)over-cap of Classical Hodgkin Lymphoma (CHL): Quantifying Response Following(A)over-cap PEM Monotherapy(A)over-cap with FDG-PLT-Derived Metabolic Tumor Volume and Total Lesion Glycolysis
    Savas, Hatice
    Allen, Pamela
    Evens, Andrew M.
    Pro, Barbara
    Dillehay, Gary
    Rademaker, Alfred
    Palmer, Brett Alan
    Advani, Ranjana
    Gordon, Leo I.
    Winter, Jane N.
    BLOOD, 2018, 132
  • [16] Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy:: 9-year follow-up
    Czuczman, MS
    Weaver, R
    Alkuzweny, B
    Berlfein, J
    Grillo-López, AJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (23) : 4711 - 4716
  • [17] Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial (vol 36, pg 1428, 2018)
    Armand
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (26) : 2748 - 2748
  • [18] A 10-year analysis of outcomes for advanced-stage Hodgkin lymphoma comparing extended follow-up of the multinational RATHL trial with real-world patients treated with ABVD or escalated BEACOPP in the East of England
    Russell, J.
    Collins, A.
    Fowler, A.
    Karanth, M.
    Saha, C.
    Docherty, S.
    Padayatty, J.
    Maw, K.
    Lentell, I.
    Cooke, L.
    Hodson, A.
    Shah, N.
    Sadullah, S.
    Grigoropoulos, N.
    Qian, W.
    Kirkwood, A.
    Uttenthal, B.
    Johnson, P.
    Follows, G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 30 - 30
  • [19] Twenty-year disease and treatment-associated mortality rates of patients with Hodgkin lymphoma of clinical stages IIIB and IV prospectively treated with 3-month anthracycline-based chemotherapy followed by extended high-dose radiation
    Senecal, Delpline
    Jais, Jean-Philippe
    Desablens, Bernard
    Berthou, Christian
    Casassus, Philippe
    Moles, Marie-Pierre
    Delwail, Vincent
    Gastinne, Thomas
    Colonna, Pierre
    Andrieu, Jean-Marie
    CANCER, 2008, 112 (04) : 846 - 855
  • [20] Anti-CD20 monoclonal antibody (Rituximab) as single agent or in combination with cytotoxic chemotherapy induces molecular remissions in heavily pre-treated or newly diagnosed patients with follicular non-Hodgkin's lymphoma.
    Martin, S
    Kronenwett, R
    Niederste-Hollenberg, A
    Meckenstock, G
    Haas, R
    BLOOD, 2000, 96 (11) : 242B - 242B
123